FinancialContent is the trusted provider of stock market information to the media industry
|
(DEPO) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
May 20, 2013
(Penny Stock DD,
8/27/12)
RTTNews) - DepoMed Inc. (DEPO:Quote) announced after the close Monday that Janssen Pharmaceuticals Inc. has licensed rights to Depomed's Acuform gastric retentive drug delivery...(read more)
On June 21, 2012, Depomed (DEPO) announced the acquisition of the product Zipsor (diclofenac potassium) Liquid Filled Capsules from privately-held Xanodyne Pharmaceuticals, Inc. Zipsor is a...(read more)
On April 17, 2012, Depomed (DEPO) announced it had completed a Type B “pre-NDA” meeting with the U.S. FDA regarding the results of the three phase 3 clinical trials for Serada (extended-release...(read more)
DepoMed (DEPO) Company Overview
There is no analysis for DEPO yet. But you can go to Wikinvest to help create one! |
| ||||||
Financial Widgets
Display market data, financial news or stock quotes - Learn More
Advertising Network
Advertise on FinancialContent's huge network - Learn More
Web Services
Power your internet and wireless applications - Learn More
